Yesterday | KPTV Beaverton
Drug Recalls Reveal More Problems
Are yesterdays miracle cures becoming today's death sentences? When we go to the doctor or ER, we assume the drugs they prescribe have been carefully tested.
Why Levaquin Mass Tort Ruling May Favor J&J
But there's reason to believe that J&J's lawyers may have pumped their fists in the air upon hearing of the decision.
Merck Prices $4.25 Billion Debt Offering
Merck & Co., Inc. priced today a $4.25 billion public offering of senior unsecured notes.
Drug 'reports' found to be faked
From the creation of fake academic journals, to bogus stories submitted to real journals, to falsified results in some of academia's most respected publications a ' the pharmaceutical industry has been rocked by allegations that the world's biggest drug companies put public relations above public safety.
Stuart Laidlaw is Going to Get Me [a] Shot from Merck
I couldn't be more pleased that [insert gratuitous but sincere praise:] outstanding Toronto Star writer Stuart Laidlaw has been rigorously following the Merck/Elsevier scandal.
Lilly `Ghostwrote' Articles to Market Zyprexa, Unsealed Case Files Show
Eli Lilly & Co. officials wrote medical journal studies about the antipsychotic Zyprexa and then asked doctors to put their names on the articles, a practice called a oeghostwriting,a according to unsealed company files.
Medical Experts Say Natural Remedies For Arthritis May Be Effective
The Institute of Food Technologists asserted new natural treatments may help improve the quality of life for more than 21 million osteoarthritis sufferers, according to new research presented at their annual meeting.
NicOx Publishes Results of the ZEST Phase 2 Study for Naproxcinod
June 9, 2009. Sophia Antipolis, France-NicOx S.A. today announced the full scientific publication of results from the ZEST phase 2 study for naproxcinod in the June issue of the Journal of Rheumatology1, an international peer-reviewed scientific journal.
Institute of Food Technologists
Natural Therapeutic Treatments for Arthritis
New natural treatments may help improve the quality of life for more than 21 million osteoarthritis sufferers, according to new research presented at the 2009 Institute of Food Technologists Annual Meeting and Food Expo.
Try Stock Advisor free for 30 days. Since 2002, David and Tom Gardner are up 31.05% vs.
Merck case will clarify investor suit time bar
The U.S. Supreme Court's decision to review a ruling against Merck & Co. Inc. will help policyholders and insurers by resolving a split among appeals courts on time limits in bringing securities fraud lawsuits, brokers and attorneys say.
Why Merck Will Win Its Vioxx Supreme Court Case
Investors allege that Merck committed securities fraud because it hid knowledge that Vioxx was dangerous until September 2004, when it was withdrawn from the market because it caused too many cardiovascular problems in patients.
Supreme Court to decide on Vioxx suits
The U.S. Supreme Court will decide whether shareholders can sue Merck over whether the drugmaker provided adequate information about the risks of its former blockbuster painkiller Vioxx before it was pulled from the market.
Court to consider whether to allow Vioxx lawsuits
WASHINGTON The Supreme Court will decide whether shareholders can sue pharmaceutical company Merck & Co.
Merck Rep Who Was on 'Survivor' Said of Vioxx: "I Knew Damn Well It Was Dangerous"
A former Vioxx sales rep for Merck who appeared on "Survivor: Gabon" told a reality TV show web site, "Selling drugs is a lie.
Merck's big push on Vioxx revealed
MARKETING documents reveal Australian staff at pharmaceutical giant Merck planned to spend $14.5 million on promotional "tactics" for its anti-arthritis drug Vioxx in one year, including $6 million on free samples.
Commissioner to probe potential privacy breaches
FEDERAL Privacy Commissioner Karen Curtis has been asked to investigate two potential breaches of privacy laws in relation to the sale or re-use of patient medical records for drug marketing purposes.
Nurses paid to scout for drug firm
AUSTRALIAN marketing staff from pharmaceutical giant Merck & Co paid specialist nurses half-a-million dollars to "hunt" through patient records for potential candidates for their blockbuster anti-arthritis drug Vioxx.
Since the government eased advertising restrictions on the pharmaceutical industry in 1997, billions and billions of dollars have been spent marketing prescription drugs to consumers.
Since the government eased advertising restrictions on the pharmaceutical industry in 1997, billions and billions of dollars have been spent marketing prescription drugs to consumers.